Journal of Experimental Medicine, Vol 180, 1619-1627, Copyright © 1994 by Rockefeller University Press

ARTICLES

In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats

S Matsuo, S Ichida, H Takizawa, N Okada, L Baranyi, A Iguchi, BP Morgan and H Okada
Third Department of Internal Medicine, Nagoya University School of Medicine, Japan.

The present work was designed to evaluate the effects of functional suppression of complement regulatory proteins in vivo. Male Wistar rats were anesthetized with Nembutal and were intravenously injected with 1 mg/kg of F(ab')2 or Fab fraction of either monoclonal antibody 5I2, which inhibits the function of rat counterpart of mouse Crry/p65, or monoclonal antibody 6D1, which inhibits the rat counterpart of CD59. Mean arterial pressure was continuously measured for 30 min. When 5I2 was injected, there was a biphasic change of mean arterial pressure, namely, the rapid increase immediately after the injection (approximately 2 min, phase 1) and the subsequent fall and slow recovery (approximately 4-30 min, phase 2). These effects were completely abrogated by pretreatment of rats with cobra venom factor. Pretreatment with carboxypeptidase inhibitor, which inhibits inactivation of anaphylatoxins C3a and C5a, induced enhanced reduction of blood pressure. Circulating leukocytes and platelets were rapidly decreased 5 min after antibody injection and became normal by 2 h. Hematocrit and erythrocyte count were continuously increased up to 2 h after injection, suggesting that there was hemoconcentration due to increased vascular permeability. Immunofluorescence study revealed binding of antibody fragments and rat C3 along the capillaries of lung, heart, and liver 5 min after injection. In contrast to 5I2, F(ab')2 fraction of 6D1, though localized to the same areas and in similar amounts, had no significant effect on the parameters measured. These data suggest that the rat counterpart of mouse Crry/p65 plays a vital role in vivo by preventing the activation of autologous complement on vascular endothelium.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Wu, X., Spitzer, D., Mao, D., Peng, S. L., Molina, H., Atkinson, J. P. (2008). Membrane Protein Crry Maintains Homeostasis of the Complement System. J. Immunol. 181: 2732-2740 [Abstract] [Full Text]  
• Brunn, G. J., Saadi, S., Platt, J. L. (2008). Constitutive Repression of Interleukin-1{alpha} in Endothelial Cells. Circ. Res. 102: 823-830 [Abstract] [Full Text]  
• Jha, P., Sohn, J.-H., Xu, Q., Wang, Y., Kaplan, H. J., Bora, P. S., Bora, N. S. (2006). Suppression of Complement Regulatory Proteins (CRPs) Exacerbates Experimental Autoimmune Anterior Uveitis (EAAU).. J. Immunol. 176: 7221-7231 [Abstract] [Full Text]  
• Asai, S., Sato, T., Tada, T., Miyamoto, T., Kimbara, N., Motoyama, N., Okada, H., Okada, N. (2004). Absence of Procarboxypeptidase R Induces Complement-Mediated Lethal Inflammation in Lipopolysaccharide-Primed Mice. J. Immunol. 173: 4669-4674 [Abstract] [Full Text]  
• Gelderman, K. A., Kuppen, P. J. K., Okada, N., Fleuren, G. J., Gorter, A. (2004). Tumor-Specific Inhibition of Membrane-Bound Complement Regulatory Protein Crry with Bispecific Monoclonal Antibodies Prevents Tumor Outgrowth in a Rat Colorectal Cancer Lung Metastases Model. Cancer Res. 64: 4366-4372 [Abstract] [Full Text]  
• Fujita, E., Farkas, I., Campbell, W., Baranyi, L., Okada, H., Okada, N. (2004). Inactivation of C5a Anaphylatoxin by a Peptide That Is Complementary to a Region of C5a. J. Immunol. 172: 6382-6387 [Abstract] [Full Text]  
• Nangaku, M. (2003). Complement Regulatory Proteins: Are They Important in Disease?. J. Am. Soc. Nephrol. 14: 2411-2413 [Full Text]  
• Fiane, A. E., Videm, V., Lingaas, P. S., Heggelund, L., Nielsen, E. W., Geiran, O. R., Fung, M., Mollnes, T. E. (2003). Mechanism of Complement Activation and Its Role in the Inflammatory Response After Thoracoabdominal Aortic Aneurysm Repair. Circulation 108: 849-856 [Abstract] [Full Text]  
• Holt, D. S., Botto, M., Bygrave, A. E., Hanna, S. M., Walport, M. J., Morgan, B. P. (2001). Targeted deletion of the CD59 gene causes spontaneous intravascular hemolysis and hemoglobinuria. Blood 98: 442-449 [Abstract] [Full Text]  
• Sohn, J.-H., Kaplan, H. J., Suk, H.-J., Bora, P. S., Bora, N. S. (2000). Chronic Low Level Complement Activation within the Eye Is Controlled by Intraocular Complement Regulatory Proteins. IOVS 41: 3492-3502 [Abstract] [Full Text]  
• Oshima, T., Okada, N., Joh, T., Sasaki, M., Tada, T., Matsukawa, N., Nomura, T., Ohara, H., Itoh, M., Okada, H. (2000). Decay-Accelerating Factor in Guinea Pig Stomachs Following Ischemia Reperfusion Stress. J. Immunol. 164: 1078-1085 [Abstract] [Full Text]  
• McGrath, Y., Wilkinson, G. W. G., Spiller, O. B., Morgan, B. P. (1999). Development of Adenovirus Vectors Encoding Rat Complement Regulators for Use in Therapy in Rodent Models of Inflammatory Diseases. J. Immunol. 163: 6834-6840 [Abstract] [Full Text]  
• Mizuno, M., Nishikawa, K., Okada, N., Matsuo, S., Ito, K., Okada, H. (1999). Inhibition of a Membrane Complement Regulatory Protein by a Monoclonal Antibody Induces Acute Lethal Shock in Rats Primed with Lipopolysaccharide. J. Immunol. 162: 5477-5482 [Abstract] [Full Text]  
• Hinchliffe, S. J., Spiller, O. B., Rushmere, N. K., Morgan, B. P. (1998). Molecular Cloning and Functional Characterization of the Rat Analogue of Human Decay-Accelerating Factor (CD55). J. Immunol. 161: 5695-5703 [Abstract] [Full Text]  
• Blok, V. T., Daha, M. R., Tijsma, O., Harris, C. L., Morgan, B. P., Fleuren, G. J., Gorter, A. (1998). A Bispecific Monoclonal Antibody Directed Against Both the Membrane-Bound Complement Regulator CD55 and the Renal Tumor-Associated Antigen G250 Enhances C3 Deposition and Tumor Cell Lysis by Complement. J. Immunol. 160: 3437-3443 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS